Zoetis to Participate in Bank of America Merrill Lynch Global Healthcare Conference
August 20 2014 - 8:30AM
Business Wire
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America
Merrill Lynch Global Healthcare Conference on Thursday, Sept. 18,
in London, UK. Juan Ramón Alaix, Chief Executive Officer of Zoetis,
will represent the company and respond to questions from analysts.
He is scheduled to present at 6:25 a.m. EDT (11:25 a.m. BST).
Investors and other interested parties will be able to access a
live audio webcast of the presentation by visiting
http://investor.zoetis.com/events-presentations. A replay of the
presentation will also be available.
About Zoetis
Zoetis (zô-EH-tis) is the leading animal health company,
dedicated to supporting its customers and their businesses.
Building on more than 60 years of experience in animal health,
Zoetis discovers, develops, manufactures and markets veterinary
vaccines and medicines, complemented by diagnostic products and
genetic tests and supported by a range of services. In 2013, the
company generated annual revenue of $4.6 billion. With
approximately 9,800 employees worldwide at the beginning of 2014,
Zoetis has a local presence in approximately 70 countries,
including 27 manufacturing facilities in 10 countries. Its products
serve veterinarians, livestock producers and people who raise and
care for farm and companion animals in 120 countries. For
more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect
the current views of Zoetis with respect to business plans or
prospects, future operating or financial performance, expectations
regarding products, future use of cash and dividend payments, and
other future events. These statements are not guarantees of future
performance or actions. Forward-looking statements are subject to
risks and uncertainties. If one or more of these risks or
uncertainties materialize, or if management's underlying
assumptions prove to be incorrect, actual results may differ
materially from those contemplated by a forward-looking statement.
Forward-looking statements speak only as of the date on which they
are made. Zoetis expressly disclaims any obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events or otherwise. A further list and
description of risks, uncertainties and other matters can be found
in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2013, including in the sections thereof captioned
“Forward-Looking Information and Factors That May Affect Future
Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on
Form 10-Q and in our Current Reports on Form 8-K. These filings and
subsequent filings are available online at www.sec.gov,
www.zoetis.com, or on request from Zoetis.
Zoetis Inc.Media Contacts:Bill
Price1-973-443-2742 (o)william.price@zoetis.comorKristen
Seely1-973-443-2777 (o)kristen.seely@zoetis.comorInvestor Contact:John O'Connor1-973-822-7088
(o)
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024